We found a positive relationship between CD36 alterations and 6 immune infiltrative cells (B cells, CD4+ T cells, CD8+ T cells, dendritic cells, macrophages, and neutrophils) and immune score across different cancer types, which indicated its role in optimizing tumor infiltrate-based predictive systems for the efficacy of ICIs. This evidence concerns the gene CD36 and cancer.